China Jo-Jo Drugstores FY EPS $(2.93) Up From $(41.46) YoY, Sales $154.54M Up From $148.81M YoY
Portfolio Pulse from Benzinga Newsdesk
China Jo-Jo Drugstores (NASDAQ:CJJD) reported a significant improvement in its fiscal year earnings per share (EPS), with losses narrowing to $(2.93) from $(41.46) year-over-year. Sales also increased by 3.85% to $154.54 million from $148.81 million.
July 30, 2024 | 1:07 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
China Jo-Jo Drugstores reported a significant improvement in its fiscal year EPS, with losses narrowing to $(2.93) from $(41.46) YoY. Sales increased by 3.85% to $154.54 million.
The significant reduction in EPS losses and the increase in sales are positive indicators for China Jo-Jo Drugstores. This improvement in financial performance is likely to boost investor confidence and positively impact the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100